deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT00716443

Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections

Open-Label, Randomized, Split-Face Study to Evaluate the Efficacy, Safety and Subject Satisfaction of Pain Management During and After Restylane® Dermal Filler Injections for the Correction of Nasolabial Folds

Sponsor: Galderma R&D

Conditions Nasolabial Folds
Interventions benzocaine 20% / lidocaine 6% / tetracaine 4% ointment tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream)
Updated 8 times since 2017 Last updated: Jul 28, 2022 Started: Jul 31, 2008 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from Galderma R&D

See all terminations from Galderma R&D

A PHASE4 clinical study on Nasolabial Folds, this trial is terminated or withdrawn. The trial is conducted by Galderma R&D and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotTerminated~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

  5. Sep 2022 — Dec 2022 [monthly]

    Terminated PHASE4

▶ Show 3 earlier versions

  1. Jan 2021 — Sep 2022 [monthly]

    Terminated PHASE4

  2. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  3. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Galderma R&D
Data source: Galderma R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations